2023
Impact of New‐Onset Conduction Disturbances following Transcatheter Aortic Valve Replacement on Outcomes: A Single‐Center Study
See C, Wang Y, Huang H, Parise H, Yang Y, Tirziu D, Francese D, Papoutsidakis N, Bader E, Kaple R, Cleman M, Lansky A, Forrest J. Impact of New‐Onset Conduction Disturbances following Transcatheter Aortic Valve Replacement on Outcomes: A Single‐Center Study. Journal Of Interventional Cardiology 2023, 2023: 5390338. PMID: 37292113, PMCID: PMC10247319, DOI: 10.1155/2023/5390338.Peer-Reviewed Original ResearchConceptsTranscatheter aortic valve replacementNew-onset conduction disturbancesAortic valve replacementPersistent conduction disturbancesConduction disturbancesValve replacementSurgical aortic valve replacementSingle-center retrospective analysisYale-New Haven HospitalSingle-center studyCause mortality ratesCause mortality riskLong-term outcomesNew Haven HospitalPeriprocedural factorsAortic stenosisConsecutive patientsTAVR proceduresTerm outcomesRetrospective analysisMortality riskMortality ratePatientsOutcomesPatient's ECG
2011
The impact of the coronary collateral circulation on mortality: a meta-analysis
Meier P, Hemingway H, Lansky AJ, Knapp G, Pitt B, Seiler C. The impact of the coronary collateral circulation on mortality: a meta-analysis. European Heart Journal 2011, 33: 614-621. PMID: 21969521, DOI: 10.1093/eurheartj/ehr308.Peer-Reviewed Original ResearchConceptsCoronary artery diseaseStable coronary artery diseaseCoronary collateral circulationMyocardial infarctionCollateral circulationRisk ratioHigh collateralizationLow collateralizationSummary risk ratiosAcute myocardial infarctionSubacute myocardial infarctionRandom-effects modelRelevant protective effectCause mortalityCoronary collateralsHard endpointsArtery diseaseCoronary collateralizationVentricular remodellingInfarct sizeClinical endpointsBlood supplyProtective effectMortality riskPatients
2009
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial
Mehran R, Pocock SJ, Stone GW, Clayton TC, Dangas GD, Feit F, Manoukian SV, Nikolsky E, Lansky AJ, Kirtane A, White HD, Colombo A, Ware JH, Moses JW, Ohman EM. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. European Heart Journal 2009, 30: 1457-1466. PMID: 19351691, PMCID: PMC2695951, DOI: 10.1093/eurheartj/ehp110.Peer-Reviewed Original ResearchConceptsAcute coronary syndromeMajor bleedingMyocardial infarctionBaseline predictorsMortality riskMajor bleedsCoronary syndromeHigh-risk acute coronary syndromesUrgent Intervention Triage Strategy (ACUITY) trialElevation acute coronary syndromeMultivariable Cox regression modelsDays of randomizationTime-updated covariatesRecurrent myocardial infarctionIndependent baseline predictorsCox regression modelShort-term riskTiming of mortalityACUITY trialAcute CatheterizationHazard ratioStrategy trialBleedingMortality hazardCox model
2003
Marked mortality risk of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction
Sadeghi H, Grines C, Mehran R, Dixon S, Lansky A, Fahy M, Cox D, Garcia E, Tcheng J, Griffin J, Guagliumi G, Stuckey T, Turco M, Carroll J, Rutherford B, Stone G. Marked mortality risk of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Journal Of The American College Of Cardiology 2003, 41: 384. DOI: 10.1016/s0735-1097(03)81097-5.Peer-Reviewed Original Research